NCT00862420View on ClinicalTrials.gov

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

431

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Peripheral Arterial Disease (PAD)

Interventions

DRUG

clopidogrel (SR25990)

oral administration (tablets)

DRUG

ticlopidine

oral administration (tablets)

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00862420 - Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter